SG11202102818YA - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents

Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Info

Publication number
SG11202102818YA
SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA
Authority
SG
Singapore
Prior art keywords
composition
patient
dryness
ocular surface
treatment
Prior art date
Application number
SG11202102818YA
Other languages
English (en)
Inventor
Markus Beier
Daniela Willen
Sonja Krösser
Thomas Schlüter
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Publication of SG11202102818YA publication Critical patent/SG11202102818YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202102818YA 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness SG11202102818YA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18196126 2018-09-22
EP18198440 2018-10-03
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (1)

Publication Number Publication Date
SG11202102818YA true SG11202102818YA (en) 2021-04-29

Family

ID=68240699

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102818YA SG11202102818YA (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Country Status (11)

Country Link
US (2) US20210346313A1 (cg-RX-API-DMAC7.html)
EP (1) EP3852734A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022500461A (cg-RX-API-DMAC7.html)
KR (1) KR20210080388A (cg-RX-API-DMAC7.html)
CN (1) CN112739335A (cg-RX-API-DMAC7.html)
AU (2) AU2019342426A1 (cg-RX-API-DMAC7.html)
CA (1) CA3111873A1 (cg-RX-API-DMAC7.html)
IL (1) IL281516A (cg-RX-API-DMAC7.html)
PH (1) PH12021550621A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202102818YA (cg-RX-API-DMAC7.html)
WO (1) WO2020058504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170087100A1 (en) 2015-09-30 2017-03-30 Novaliq Gmbh Semifluorinated compounds and their compositions
DK3442480T3 (da) 2016-06-23 2020-01-13 Novaliq Gmbh Fremgangsmåde til topisk indgivelse
KR102614858B1 (ko) 2016-09-22 2023-12-18 노바리크 게엠베하 안검염 치료에 사용되는 약제학적 조성물
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
MX381639B (es) 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
PL3612228T3 (pl) 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
JP7814839B2 (ja) 2017-09-27 2026-02-17 ノバリック ゲーエムベーハー 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
US11576893B2 (en) 2018-03-02 2023-02-14 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
AU2019246035B2 (en) 2018-03-28 2024-07-18 Novaliq Gmbh Pharmaceutical composition comprising timolol
JP7855312B2 (ja) 2018-04-27 2026-05-08 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
EP3923907B1 (en) 2019-02-13 2024-09-25 Novaliq GmbH Compositions and methods for the treatment of ocular neovascularization
CN114449999A (zh) 2019-09-06 2022-05-06 诺瓦利克有限责任公司 用于治疗葡萄膜炎的眼用组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
EP2187900B1 (en) * 2007-08-16 2016-11-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
EP2895144B1 (en) * 2012-09-12 2017-01-11 Novaliq GmbH Semifluorinated alkane compositions
MX363182B (es) * 2012-09-12 2019-03-13 Novaliq Gmbh Composiciones que comprenden mezclas de alcanos semifluorados.
EP3187168B1 (en) * 2014-10-09 2020-03-18 Mediproduce Inc. Eyelash cleaning agent
US20170087100A1 (en) * 2015-09-30 2017-03-30 Novaliq Gmbh Semifluorinated compounds and their compositions
KR102614858B1 (ko) * 2016-09-22 2023-12-18 노바리크 게엠베하 안검염 치료에 사용되는 약제학적 조성물
CN111182893A (zh) * 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物

Also Published As

Publication number Publication date
KR20210080388A (ko) 2021-06-30
EP3852734A1 (en) 2021-07-28
US20250295607A1 (en) 2025-09-25
PH12021550621A1 (en) 2022-02-14
JP2022500461A (ja) 2022-01-04
US20210346313A1 (en) 2021-11-11
WO2020058504A1 (en) 2020-03-26
AU2025204313A1 (en) 2025-06-26
IL281516A (en) 2021-04-29
AU2019342426A1 (en) 2021-05-20
CA3111873A1 (en) 2020-03-26
CN112739335A (zh) 2021-04-30

Similar Documents

Publication Publication Date Title
IL278178A (en) Use of pilocarpine hydrochloride to treat eye disorder
IL281773B2 (en) Ophthalmic preparation for the treatment of dry eye disease
PH12021550621A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
IL284344A (en) Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye
PT3399962T (pt) Composição oftálmica para o tratamento da doença do olho seco
EP3463315C0 (en) COMPOSITIONS AND METHODS OF USE OF NINTEDANIB FOR THE TREATMENT OF ABNORMAL NEOVASCULARIZATION OCULAR DISEASES
SG11202102615RA (en) Methods and compositions for ocular cell therapy
ZA202002991B (en) Methods and compositions for assessing and treating intraocular diseases and disorders
IL287802A (en) Preparations and methods for the treatment of eye diseases
IL277557A (en) Self-assembling peptidomimetics and peptidomimetics for the treatment of eye diseases
ZA202107235B (en) Compositions and methods for treating ocular disease
SMT202300093T1 (it) Composizione oftalmica nutraceutica per il trattamento di patologie retiniche a componente neovascolare
EP3691654A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES
PL3493823T4 (pl) Składnik na bazie postbiotyki do leczenia zapalenia oka
SMT201900621T1 (it) Composizione oftalmica per l'uso nel trattamento dei disturbi dell'occhio relativi alle alterazioni della superficie corneale-congiuntivale
PT4031117T (pt) Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos
EP3644966A4 (en) TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS
SG11202012473UA (en) Ophthalmic compositions and methods for the treatment of eye disorders
IL287441A (en) Preparations and methods of use for the treatment of dry eye
SG11202004940VA (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
HK40058269A (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
IL280588A (en) Ophthalmic compositions and methods for treating eye problems and skin diseases
HK40033459A (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases